## Abstract A concise, yet objective overview of Hepatocellular Carcinoma (HCC) treatment in 2006 with an intent to transplant is presented. The most significant variables impacting on the use of hepatic transplantation as therapy for primary liver cancer are developed under the headings of: Stagin
Liver transplantation for primary and secondary hepatic apudomas
β Scribed by J. C. Arnold; J. G. O'Grady; G. L. Bird; R. Y. Calne; Dr. R. Williams
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 264 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 57-year-old gentleman with a past medical history significant for Hodgkin's lymphoma in 1977 (which required splenectomy, radiation therapy, and chemotherapy) was incidentally found to have a large left lobe liver mass in July 2008 while he was undergoing computed tomography imaging for presumed n
Two patients undergoing liver transplantation for classical end-stage primary biliary cirrhosis (PBC) are described, who went on to develop de novo autoimmune hepatitis (AIH) in the transplanted liver. The presentation, in both instances, was with malaise and lethargy. Markedly elevated serum transa
iver transplantation for patients with hepatitis B infection is rapidly changing. The initial L experience of dismal graft and patient survival rates has resulted in denial of reimbursement by many private and federal insurance carriers. This has been tempered by better selection of candidates and t